Skip to search formSkip to main contentSkip to account menu

Scleroderma Renal Crisis

The onset of acute renal failure, normally coupled with marked hypertension in a patient with scleroderma.
National Institutes of Health

Related topics

Related topics

3 relations
KidneyKidney DiseasesUrinary system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Scleroderma renal crisis and renal involvement in systemic sclerosis
Scleroderma renal crisis (SRC) is a rare, potentially life-threatening complication that affects 2–15% of patients with systemic… 
Review
2011
Review
2011
Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis
Scleroderma renal crisis (SRC) is a major complication in patients with systemic sclerosis (SSc). It is characterized by… 
Highly Cited
2010
Highly Cited
2010
Scleroderma Renal Crisis: A Pathology Perspective
Scleroderma renal crisis (SRC) is an infrequent but serious complication of systemic sclerosis (SSc). It is associated with… 
Highly Cited
2007
Highly Cited
2007
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
Objectives: To describe presentation and outcome of patients with scleroderma renal crisis (SRC). Methods: SRC was defined as… 
Review
2007
Review
2007
Vascular complications of scleroderma.
Review
2006
Review
2006
Renal complications and scleroderma renal crisis.
Scleroderma renal crisis (SRC) occurs in 5-10% of SSc patients, who may present with an abrupt onset of hypertension, acute renal… 
Review
2006
Review
2006
Overview of pathogenesis of systemic sclerosis.
The aetiology of SSc is subject to ongoing research, as the precise events that underlie the development of this disease remain… 
Highly Cited
2000
Highly Cited
2000
Long-Term Outcomes of Scleroderma Renal Crisis
Scleroderma renal crisis (1) is defined as the new onset of severe hypertension associated with a rapid increase in serum… 
Highly Cited
1999
Highly Cited
1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
OBJECTIVE To test the hypothesis that systemic sclerosis (SSc) patients taking high-dose D-penicillamine (D-Pen) would have… 
Highly Cited
1998
Highly Cited
1998
Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
OBJECTIVE To determine whether the initiation of corticosteroids or other types of therapy affects the development of scleroderma… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)